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Abstract: People who either use an upper limb prosthesis and/or have used services provided
by a prosthetic rehabilitation centre, hereafter called users, are yet to benefit from the fast-paced
growth in academic knowledge within the field of upper limb prosthetics. Crucially over the past
decade, research has acknowledged the limitations of conducting laboratory-based studies for clinical
translation. This has led to an increase, albeit rather small, in trials that gather real-world user
data. Multi-stakeholder collaboration is critical within such trials, especially between researchers,
users, and clinicians, as well as policy makers, charity representatives, and industry specialists. This
paper presents a co-creation model that enables researchers to collaborate with multiple stakeholders,
including users, throughout the duration of a study. This approach can lead to a transition in
defining the roles of stakeholders, such as users, from participants to co-researchers. This presents a
scenario whereby the boundaries between research and participation become blurred and ethical
considerations may become complex. However, the time and resources that are required to conduct
co-creation within academia can lead to greater impact and benefit the people that the research aims
to serve.
Keywords: co-creation; collaboration; upper limb prosthetics; user needs
1. Introduction
The aim of the paper is to present a perspective of how co-creation can enable collabo-
ration with multiple stakeholders throughout a research study. Within the field of upper
limb prosthetics, we share our perspective on how co-creation can facilitate a transition
from short-term laboratory-based testing, to long-term in-home trials. Additionally, we
Prosthesis 2021, 3, 110–118. https://doi.org/10.3390/prosthesis3020012 https://www.mdpi.com/journal/prosthesis
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offer our broad perspective on the challenges and opportunities of how co-creation can
contribute to the translation of academic knowledge into clinical practice.
Translating research into clinical practice for the benefit of users of upper limb pros-
thetics has been notoriously slow. As aforementioned, with the term “users” we refer to
people who either use an upper limb prosthesis and/or have used the services provided
by a prosthetic rehabilitation centre. The last two decades have seen increased academic
interest in prosthesis user needs and satisfaction [1–18]. However, proposed advancements
that address the identified needs have not led to a reduction in device abandonment,
which has highlighted the gap between published research and its translation into clinical
practice [6,19]. Furthermore, evidence has highlighted that laboratory metrics and findings
are not always consistent with clinical and/or outcomes of importance to users [20]. This
exposes a limited understanding of how devices and/or systems fit within the daily lives
and routines of users, for example, within a home environment where experimental con-
straints are relaxed [21–23]. The current rate of progress in addressing user needs poses an
opportunity to explore how different research approaches can lead to advancement [24]. By
incorporating user-centred information throughout all stages of research, new knowledge
can be generated that may reduce the gap between academic developments and positive
impacts on prosthesis users’ experience in their everyday lives.
2. Background
In recent years, translational healthcare research, which aims to translate research
into practice to reach patients [25], has experienced benefits of expanding the range of
collaborative stakeholders [26,27]. Within pharmaceutical development, open innovation
has enabled collaboration between researchers, industry agencies, users, and policy mak-
ers [26]. Open innovation provides a framework that enables research teams to conduct
external collaborations by sharing information, resources, and intellectual property [28].
Within healthcare, collaboration with patients and oncology nurses has resulted in studies
that identify improvements for cancer diagnosis services, such as mobile applications [29].
Within assistive technology, studies have presented how using techniques to engage a
range of stakeholders can assist in creating solutions that integrate into people’s lives, for
example, rehabilitation advancement for people with multiple sclerosis [30], and techno-
logical innovation for people living with dementia [31]. Living laboratories that monitor
everyday activities of people within real-life scenarios have enabled researchers to evaluate
the usability of healthcare technologies and assess health outcomes [32]. Participatory
research methods implemented within living laboratories have provided an opportunity
for users to share feedback and suggestions for solution improvements [32]. A consistent
factor within these examples is the involvement of patients or users, as collaborators within
the research process, and how their involvement informs research outcomes. Co-creation
Figure 1 can be an approach to facilitate such a form of collaboration, in particular between
researchers, users, and clinicians.
Co-creation is an approach that emerged from participatory design practice, with a
focus on generating ideas with users as partners rather than subjects/participants [33].
The past two decades have seen an increase in co-creation within many fields, which has
led to variations of definition [33,34]. Figure 1 presents the definition of co-creation that
the article will use, which seeks to assist in translating new knowledge into healthcare
practice [35]. The definition presents four processes that facilitate collaboration with
multiple stakeholders throughout a study, which can be applied to prosthetic research.
Collaboration with academic, clinical, and industrial stakeholders throughout a study
can lead to academic publication and intellectual property in the short term. Broadening the
range of stakeholders to include users, policy makers, and representatives from charitable
and/or non-governmental organisations can facilitate the translation of knowledge into
clinical practice in the long term [36]. This is especially evident when users directly con-
tribute towards research studies by providing input based on their lived experiences [37].
Collaboration with users can lead to collecting real-world data, which can inform health-
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care policy evidence [38,39]. The implementation of co-creation throughout the duration
of research studies can lead towards a significant step-change in how research practice
develops within the field of upper limb prosthetics.




Figure 1. Co-creation definition. Quotation from Pearce [35]. 
Collaboration with academic, clinical, and industrial stakeholders throughout a 
study can lead to academic publication and intellectual property in the short term. Broad-
ening the range of stakeholders to include users, policy makers, and representatives from 
charitable and/or non-governmental organisations can facilitate the translation of 
knowledge into clinical practice in the long term [36]. This is especially evident when us-
ers directly contribute towards research studies by providing input based on their lived 
experiences [37]. Collaboration with users can lead to collecting real-world data, which 
can inform healthcare policy evidence [38,39]. The implementation of co-creation through-
out the duration of research studies can lead towards a significant step-change in how 
research practice develops within the field of upper limb prosthetics. 
3. Application to Upper Limb Prosthetic Research 
The co-creation approach presented in Figure 2 presents an example of how multiple 
stakeholders can collaborative flexibly throughout a prosthetic research study. The ap-
proach, based on Pearce [35], was developed to present an example of (1) how the four 
collaborative processes of co-creation could occur over the duration of a research study, 
and (2) how a combination of stakeholders could collaborate throughout the approach. 
All four collaborative processes of co-creation occur within each stage of prosthetic 
research, namely, research proposal development, experimental design, analysis of re-
sults, and dissemination of knowledge. In practice, research can be iterative, compared to 
the linear stages presented in Figure 2. However, Figure 2 presents an example of an 
adaptable reference point, based on the broad trajectory that research studies follow.  
The core and peripheral stakeholders presented in Figure 2 document an example of 
how this approach could facilitate collaboration with a range of people throughout a 
study. The combination of stakeholders and their involvement in each collaborative pro-
cess may vary at each research stage, depending upon the study, as illustrated in Figure 
3. Core stakeholders are integral to the work within a study stage, by providing 
knowledge, expertise, and informed opinion. Collaboration with peripheral stakeholders 
occurs on an as-needed basis, with their participation contributing to the range of relevant 
opinions and expertise.  
Based on the stakeholder combination presented in Figure 2, core stakeholders could 
become involved in the proposal stage by developing a collaborative proposed pro-
gramme of research. Within the experiment stage, core stakeholders could collaborate to 
develop experimental protocols. Within the analysis stage, users could influence future 
studies by sharing their experience of the research, which could also inform published 
research within the dissemination stage. Figure 2 presents all stakeholders as core in the 
dissemination stage, as all parties can share research findings collaboratively and within 
their own respective fields. Furthermore, the involvement of policy makers at each stage 
Figure 1. Co-creation definition. Quotation from Pearce [35].
3. Application to Upper Limb Prosthetic Research
The co-creation approach presented in Figure 2 presents an example of how multi-
ple stakeholders can collaborative flexibly throughout a prosthetic research study. The
approach, based on Pearce [35], was developed to present an example of (1) how the four
collaborative processes of co-creation could occur over the duration of a research study,
and (2) how a combination of stakeholders could collaborate throughout the approach.
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Figure 2. Co-creation model for upper limb prosthetics.
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All four collaborative processes of co-creation occur within each stage of prosthetic
research, namely, research proposal development, experimental design, analysis of results,
and dissemination of knowledge. In practice, research can be iterative, compared to the
linear stages presented in Figure 2. However, Figure 2 presents an example of an adaptable
reference point, based on the broad trajectory that research studies follow.
The core and peripheral stakeholders presented in Figure 2 document an example of
how this approach could facilitate collaboration with a range of people throughout a study.
The combination of stakeholders and their involvement in each collaborative process
may vary at each research stage, depending upon the study, as illustrated in Figure 3.
Core stakeholders are integral to the work within a study stage, by providing knowledge,
expertise, and informed opinion. Collaboration with peripheral stakeholders occurs on
an as-needed basis, with their participation contributing to the range of relevant opinions
and expertise.




Figure 3. Co-creation for an in-home trial—a potential user journey map. 
Recruitment of users to in-home trials can be achieved through building relationships 
with existing research participants or forming new relationships through avenues, such 
as social media or connections to rehabilitation centres. Communication methods between 
researchers and users is key within the recruitment process. To that end, a variety of meth-
ods can be conducted, for example, project videos, text and pictorial documents, and 
phone and/or video conversations. Accessibility considerations are key within the recruit-
ment process, ensuring that chosen mediums are accessible to all involved. Identifying 
clear inclusion criteria is beneficial when recruiting users to such studies. Given the lon-
gitudinal nature of in-home trials, which can run over several years, researchers and users 
can benefit from establishing how to work together and build relationships over a long-
term basis. Initially, this can be addressed by defining stakeholder roles and responsibili-
ties from the study onset.  
Building collaborative relationships between researchers and users is based on form-
ing trust through ensuring transparency between both parties and conducting ongoing 
informed consent [44]. Conducting research with users that incorporates user input from 
an early project stage can assist in forging strong relationships between stakeholders and 
lead to an effective research experience for all involved [40]. The key aspect of the model 
presented in Figure 2 is the identification of users as core stakeholders within all four 
study stages and the range of core stakeholders at the dissemination stage. This range of 
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Based on the stakeholder combination presented in Figure 2, core stakeholders could
becom involved in the proposal stage by developing a collaborative proposed programme
of research. Within the experiment st ge, core stakeholders co ld ollaborate to develop
experimental protocols. Within t e analysis stage, users could influence future studies by
sharing their experience of the research, which could also inform published research withi
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the dissemination stage. Figure 2 presents all stakeholders as core in the dissemination
stage, as all parties can share research findings collaboratively and within their own
respective fields. Furthermore, the involvement of policy makers at each stage of the
approach enables research teams to create an on-going connection between research and
policy. Figure 2, as aforementioned, is an example of a co-creation approach for upper limb
prosthetics; other examples within the field are also documented, which present a range of
collaborative stakeholders throughout a study [40].
An emerging route towards clinical translation for upper limb prosthetics is in-home
trials [41], which presents a scenario whereby research transcends the laboratory, entering
into home environments. Whilst in-home trials are technologically feasible [22,23,42,43],
strategies that enable stakeholder collaboration within this context are not currently doc-
umented within the literature. Co-creation can be used as an approach to enable such
collaboration; an example of which is presented in Figure 3, which illustrates one way that
user involvement could occur throughout an in-home trial. The four stages of research
presented in Figure 3 are in linear form; however, iteration across the stages and within
the collaborative processes of co-creation is possible in practice. For example, during the
proposal stage, users can influence the proposed research by providing feedback, and
sharing experiences of using a prosthesis within the home. During the experiment stage,
users can collaboratively develop experimental protocols, with a focus on the context of
in-home trials, including opinions of remote data collection. The refinement of the protocol
may require iteration, such as between co-ideate and co-evaluate within the experiment
stage. Based on the experience of an in-home trial, users can influence the summary of
findings within the analysis stage; including the identification of outcome measures in
relation to the study. This can lead to forming recommendations for future studies. Fur-
thermore, during the dissemination stage, users can contribute to peer reviewed articles
and conference proceedings as co-authors and share research findings at outreach events.
Recruitment of users to in-home trials can be achieved through building relationships
with existing research participants or forming new relationships through avenues, such as
social media or connections to rehabilitation centres. Communication methods between re-
searchers and users is key within the recruitment process. To that end, a variety of methods
can be conducted, for example, project videos, text and pictorial documents, and phone
and/or video conversations. Accessibility considerations are key within the recruitment
process, ensuring that chosen mediums are accessible to all involved. Identifying clear
inclusion criteria is beneficial when recruiting users to such studies. Given the longitudinal
nature of in-home trials, which can run over several years, researchers and users can benefit
from establishing how to work together and build relationships over a long-term basis.
Initially, this can be addressed by defining stakeholder roles and responsibilities from the
study onset.
Building collaborative relationships between researchers and users is based on form-
ing trust through ensuring transparency between both parties and conducting ongoing
informed consent [44]. Conducting research with users that incorporates user input from
an early project stage can assist in forging strong relationships between stakeholders and
lead to an effective research experience for all involved [40]. The key aspect of the model
presented in Figure 2 is the identification of users as core stakeholders within all four
study stages and the range of core stakeholders at the dissemination stage. This range of
collaborative stakeholders can lead to greater success in translating academic research into
clinical practice.
4. Challenges and Opportunities
The scenario presented above illustrates a transition in defining user involvement
within research from participants to co-researchers. Such an approach comes with risks, for
example, the blurring of the boundaries between research and everyday life could have
a negative impact on users. Ethical considerations can therefore become more complex,
for example, ensuring that meaningful, informed consent is obtained throughout the
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study [44]. In addition, the design of blinded experiments in collaboration with users is a
pertinent consideration, such that biases are addressed. A key principle to be addressed
and re-visited throughout the duration of a co-creation study is power sharing, which
identifies research as jointly owned through neutral understanding [45]. Adopting an
approach that involves users as core stakeholders will be challenging [37]. However,
resources are available to assist the exploration of ethical considerations in collaboration
with stakeholders throughout the course of a study, such as The Ethical Roadmap [46].
Furthermore, existing examples demonstrate that including users can lead to capturing new
knowledge and experience that is vital in conducting meaningful, impactful research [47].
Therefore, it is timely to establish how co-creation can successfully work in practice.
5. Suggestions for the Field
Collaboration between academics and users is central to co-creation, which is sup-
ported by the definition of patient and public involvement: researching with people, rather
than for people [48]. Conducting academic research with patients and/or the public has
been facilitated by recent changes to ethical review mechanisms, which are proportionate to
the level of risk within the study [49]. National and international research funders publish
calls that require patient and public involvement within studies that are proposed. In
addition, pairing schemes that provide opportunities to build knowledge of how policy is
informed by research evidence can provide a platform to develop collaboration between
academic and governmental partners [50]. However, a top-down approach can influence
the challenges that are addressed by academic research, in addition to the research methods
that are utilised. This is in contrast to a bottom-up structure whereby a population, such as
a user group, defines a challenge and the methods that could be used to conduct research
within that field. Consequently, a top-down approach can lead to tokenism, which may
not result in co-created research that address the needs of a population [51]. Furthermore,
the time required to implement co-creation can be deemed impractical, especially for
early career researchers, due to contract duration and lack of career incentives for this
area of research [52]. Given the multi-disciplinary nature of co-creation, from a broad
perspective, academic institutions may benefit from assessing how studies are facilitated
by current structures and career progression routes. Academic institutions can adopt a
phased approach, which could be initiated by re-addressing incentives for conducting
public involvement [52].
The rapid growth of online collaborative platforms during the Covid-19 pandemic
has provided new possibilities to address the challenges of allocating time and identifying
convenient locations to bring stakeholders together throughout a project. This is especially
beneficial to users who require flexibility and balance in their own work and personal
responsibilities, alongside their contribution to academic research. In addition, the techno-
logical capability of connecting multiple people through internet enabled devices, termed
the Internet of Things, has provided remote methods of user interaction with clinical and
academic teams within the field of rehabilitation [53]. Advancements in technology have
enabled such forms of engagement within research; however, there are people who are
digitally excluded from such studies, based on internet and device accessibility, and digital
literacy [54].
Collaboration between academics and clinicians, as presented in Figure 2, can provide
a bridge that connects researchers with users [55], which forms a collegiality whereby users
can contribute throughout the research process.
6. Conclusions
The growth of user-centred studies within healthcare research generally presents an
opportunity to identify approaches that can enable collaboration with multiple stakehold-
ers throughout a study. Co-creation has the potential to aid in realising this opportunity,
by identifying users as core stakeholders. Given the dynamic range of input that each
stakeholder provides, the future of co-creation depends, in-part, on forming an inclusive
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approach that nurtures collaboration, especially between researchers and users. Now is
the time to implement co-creation and frame its contribution towards enabling academic
knowledge to translate into long-term user benefits and positive impacts, through the ad-
vancement of upper limb prosthetic devices and the overarching ecosystem of clinical care.
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